C Difficile Infection

Children with unconfirmed PALs have prolonged hospital stays, higher rates of adverse events, and more infections due to Clostridium difficile and vancomycin-resistant Enterococcus.

The recurrent CDI cohort were nearly 10 times likelier to suffer from a CDI-associated death than the primary CDI cohort.

USPSTF experts noted a need for research into the benefits and harms of screening adults and adolescents without signs or symptoms.

Ribotype 046 was highly prevalent during the 2011 C difficile outbreak at a hospital in Sweden.

Clinical improvement was identified in 63% of patients treated with continuous enteral vancomycin.

While orders for C difficile toxin tests dropped significantly, the negative test rates did not differ much in recipients of solid organ transplantations.

Patients with diarrhea did have longer hospital stays than patients without diarrhea.

Long-term care facilities were able to see a reduction in antibiotic starts and days of antibiotic therapy by engaging in an antibiotic stewardship program.

The new hospital featured 50% private rooms, as well as regular cleaning and other preventative measures for C difficile infections.

The investigators found 56.7% of nursing home patients and 68.1% had multi-drug resistant organism-positive results at enrollment.

Both single-donor and multiple-donor fecal microbiota transplantation had clinical cure rates over 80%.

Hospitals with lower-than-expected CDI antimicrobial use had on average fewer beds, shorter length of stay, and higher proportion of undergraduate or nonteaching medical school affiliation.

Resmetirom is being studied as a potential treatment for both NAFLD and NASH.

Due to costs, it is difficult to screen for and diagnose patients with C difficile infections.

Only 12% of SER-109 treated patients had a recurrence, compared to 40% of the placebo group.

Periprocedural antimicrobial prophylaxis are administered and in some cases continued for extended periods of time while the patient has a surgical drain in place.

The 6 recommendations across 2 expert-led guidelines address the role of colonoscopy, CT scans and elective surgery, among other subjects of care.

About 25% of C difficile infections are due to community spread.

Exposure to long-term prescription opioid therapy was linked to a 3.2-fold higher risk of HCV seroconversion compared to individuals who were prescription opioid-naïve or acute.

Adverse event rates did not significantly differ between patients treated with both DAV132 and Fluoroquinolone and patients treated only with fluoroquinolone.

The prototype is being tested in clinical trials involving live microbiota therapeutics as a treatment for recurrent C difficile infections.

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.

Patients who receive a solid organ transplant and develop CDI are at an increased risk for an acute kidney injury.

These changes to the previous 2013 ACG Guidelines feature evidence-based guidance for the evaluation of gastroesophageal reflux disease that include pharmacologic, lifestyle, surgical, and endoscopic management efforts.

A positive CDI test was more common in patients with suffered an aneurysmal subarachnoid hemorrhage than it was in patients with intracerebral hemorrhage or ischemic stroke.